Pharmacy World and Science

, Volume 17, Issue 4, pp 96–102 | Cite as

Practical strategies for the appropriate use of antimicrobials

  • B. Joseph Guglielmo


The use and misuse of antimicrobial agents is well documented in the literature. A variety of mechanisms has been used to enhance the appropriate use of these agents. A widely used initial strategy is the formation of multidisciplinary groups, such as Pharmacy and Therapeutics Committees or antimicrobial subcommittees, which are responsible for all antimicrobial policies for the health-care facility. Other techniques include the use of antimicrobial order sheets, automatic stop orders, therapeutic substitution, antibiotic restriction systems, and the use of selective antimicrobial susceptibility reporting systems. Many of these strategies have been reported to be effective in the management of antimicrobial usage; however, they also result in increased administrative and monitoring costs. Antimicrobial control systems must be individualized to the health-care facility.


Anti-infective agents Costs and cost analysis Dosage Drug resistance, microbial Drug utilization Formularies Pharmacy and therapeutics committee 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79:555–60.PubMedGoogle Scholar
  2. 2.
    Jacoby GA, Archer G. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324:601–12.PubMedGoogle Scholar
  3. 3.
    Sanders CC, Sanders WE. β-lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824–39.PubMedGoogle Scholar
  4. 4.
    Georgopapadakou NH. Penicillin-binding proteins and bacterial resistance to β-lactams. Antimicrob Agents Chemother 1993;37:2045–53.PubMedGoogle Scholar
  5. 5.
    Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the advisory council for the elimination of tuberculosis. JAMA 1993;270:694–8.Google Scholar
  6. 6.
    Boken DJ, Seindells S, Rinaldi MG. Fluconazole-resistantCandida albicans. Clin Infect Dis 1993;17:1018–21.PubMedGoogle Scholar
  7. 7.
    Guglielmo BJ, Brooks GF. Antimicrobial therapy. Cost-benefit considerations. Drugs 1989;38:473–80.PubMedGoogle Scholar
  8. 8.
    Corelli RL, Guglielmo BJ, Carroll DJ, Aweeka FT, Gambertoglio JG, Winter ME. Development of a hospitalwide adult antimicrobial dosing guideline. New Orleans (LA): American Society of Hospital Pharmacists Midyear Clinical Meeting, 1991;26(Dec):MCS-65.Google Scholar
  9. 9.
    Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med 1992;152:554–7.PubMedGoogle Scholar
  10. 10.
    Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, Spivey JM, et al. Use of antimicrobial drugs in adults before and after removal of a restriction policy. Am J Hosp Pharm 1991;48:1220–7.PubMedGoogle Scholar
  11. 11.
    DeVito JM, John JF. Effect of formulary restriction of cefotaxime usage. Arch Intern Med 1985;145:1053–6.PubMedGoogle Scholar
  12. 12.
    Noel MW, Paxinos J. Cephalosporins. Use review and cost analysis. Am J Hosp Pharm 1978;35:933–5.PubMedGoogle Scholar
  13. 13.
    Nightengale J, Chaffee BW, Colvin CL, Alexander MR, Rice R, Ross MB. Retrospective evaluation of vancomycin use in a university hospital. Am J Hosp Pharm 1987;44:1807–9.PubMedGoogle Scholar
  14. 14.
    DeTorres OH, White RE. Effect of aminoglycoside-use restrictions on drug cost. Am J Hosp Pharm 1984;41:1137–9.PubMedGoogle Scholar
  15. 15.
    Fletcher CV, Giese RM, Rodman JH. Pharmacist interventions to improve prescribing of vancomycin and tobramycin. Am J Hosp Pharm 1986;43:2198–2201.PubMedGoogle Scholar
  16. 16.
    Dzierba SH, Reilly RT, Caselnova DA III. Cost savings achieved through cephalosporin use review and restriction. Am J Hosp Pharm 1986;43:2194–7.PubMedGoogle Scholar
  17. 17.
    Nickman NA, Blissenbach HF, Herrick JD. Medical committee endorsement of policy limiting postsurgical antibiotic use in a university hospital. Am J Hosp Pharm 1984;41:2053–6.PubMedGoogle Scholar
  18. 18.
    Frighetto L, Nickoloff D, Martinusen SM, Mamdani FS, Jewesson PJ. Intravenous to oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992;26:1447–51.PubMedGoogle Scholar
  19. 19.
    Ehrenkranz NJ, Nerenberg DE, Shultz JM, Slater KC. Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening patient stay. Infect Control Hosp Epidemiol 1992;13:21–32.PubMedGoogle Scholar
  20. 20.
    Janknegt R, van der Meer JWM. Antimicrobial practice. Sequential therapy with intravenous and oral cephalosporins. J Antimicrob Chemother 1994;33:169–77.PubMedGoogle Scholar
  21. 21.
    Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of antimicrobial susceptibility test results and physician prescribing patterns. Am J Hosp Pharm 1989;46:1816–8.PubMedGoogle Scholar
  22. 22.
    Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988;148:1720–4.PubMedGoogle Scholar
  23. 23.
    Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic utilization reviews: influence on physicians' prescribing patterns. J Infect Dis 1984;150:803–7.PubMedGoogle Scholar
  24. 24.
    Durbin WA, Lapidas B, Goldmann DA. Improved antibiotic usage following introduction of a novel prescription system. JAMA 1981;246:1796–1800.PubMedGoogle Scholar
  25. 25.
    Corelli R, Guglielmo BJ. Use of an antimicrobial order sheet in a university teaching hospital. San Diego (CA): American Society of Hospital Pharmacists Annual Meeting, 1991; 48(Jun):P-21DGoogle Scholar
  26. 26.
    Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol 1990;11:578–83.PubMedGoogle Scholar
  27. 27.
    Moleski RJ, Andriole VT. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986;8:488–93.PubMedGoogle Scholar
  28. 28.
    Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90:439–44.PubMedGoogle Scholar
  29. 29.
    Pastel DA, Chang S, Nessim S, Shane R, Morgan MA. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy. Hosp Pharm 1992;27:596–614.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1995

Authors and Affiliations

  • B. Joseph Guglielmo
    • 1
  1. 1.Division of Clinical PharmacyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations